SLAMSEQ Trademark

Trademark Overview


On Wednesday, February 28, 2018, a trademark application was filed for SLAMSEQ with the United States Patent and Trademark Office. The USPTO has given the SLAMSEQ trademark a serial number of 79235946. The federal status of this trademark filing is PARTIAL SECTION 71 ACCEPTED as of Wednesday, May 21, 2025. This trademark is owned by IMBA - Institut für Molekulare Biotechnologie GmbH. The SLAMSEQ trademark is filed in the Computer & Software Services & Scientific Services, Chemical Products, and Pharmaceutical Products categories with the following description:

[ Pharmaceutical products, namely, nucleic acid molecules for use in identification of genotypes, for the preparation of biopolymer profiles, for the detection of diseases, for the detection of the progression of diseases as well as for the detection of reactions to medicines; diagnostic reagents for medical purposes in the diagnosis of inflammations, infections, diseases of the central nervous system, cardiovascular, neurologic, endocrine, autoimmune and genetic diseases and of cancer, consisting of reagents, processing chemicals and nucleic acid molecules; medical diagnostic test kits for the detection of pathogens in the environment; clinical and diagnostic reagents and preparations for medical and veterinary purposes; medical diagnostic test kits for identification, quantification and analysis of DNA or RNA; reagents and enzymes for use with effecting DNA- or RNA-analysis for medical purposes ]

Chemical and biochemical preparations for industrial and scientific purposes; chemical preparations for biotechnical purposes (industrial); chemical preparations for use in the development of biotechnological products for industrial and scientific purposes; chemical reagents and preparations for scientific purposes; chemical substances for analysis in laboratories and for use in kits; diagnostic reagents for in-vitro use in clinical chemistry; diagnostic preparations, except for medical or veterinary purposes; enzymes, in particular for use in kits and for use in effecting DNA-analysis or RNA-analysis and for enzyme preparations; all aforementioned goods for industrial and scientific purposes; reagents for scientific purposes

Scientific and technological services, namely, scientific research, development, diagnosis and analysis in the field of diagnostic chemicals and reagents, sorting of nucleotides, separation processes and cleaning processes, chemical screening analysis and effecting of diagnostic, forensic and genetic-medical tests for thirds; scientific research and development for thirds in the fields of diagnostic chemical agents and reagents for use as diagnostic, therapeutic preparations, as well as chemical screenings and diagnosis for thirds; scientific research and development of pharmaceutical preparations for sanitary use; design of new products regarding pharmaceutical products; quality tests and quality control of scientific analyses relating to nucleic acids; scientific analyses relating to nucleic acids, in particular for detection purposes
slamseq

General Information


Serial Number79235946
Word MarkSLAMSEQ
Filing DateWednesday, February 28, 2018
Status707 - PARTIAL SECTION 71 ACCEPTED
Status DateWednesday, May 21, 2025
Registration Number5658617
Registration DateTuesday, January 22, 2019
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, November 6, 2018

Trademark Statements


Description of MarkThe mark consists of the word "SLAMSEQ" in stylized form.
Goods and Services[ Pharmaceutical products, namely, nucleic acid molecules for use in identification of genotypes, for the preparation of biopolymer profiles, for the detection of diseases, for the detection of the progression of diseases as well as for the detection of reactions to medicines; diagnostic reagents for medical purposes in the diagnosis of inflammations, infections, diseases of the central nervous system, cardiovascular, neurologic, endocrine, autoimmune and genetic diseases and of cancer, consisting of reagents, processing chemicals and nucleic acid molecules; medical diagnostic test kits for the detection of pathogens in the environment; clinical and diagnostic reagents and preparations for medical and veterinary purposes; medical diagnostic test kits for identification, quantification and analysis of DNA or RNA; reagents and enzymes for use with effecting DNA- or RNA-analysis for medical purposes ]
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesChemical and biochemical preparations for industrial and scientific purposes; chemical preparations for biotechnical purposes (industrial); chemical preparations for use in the development of biotechnological products for industrial and scientific purposes; chemical reagents and preparations for scientific purposes; chemical substances for analysis in laboratories and for use in kits; diagnostic reagents for in-vitro use in clinical chemistry; diagnostic preparations, except for medical or veterinary purposes; enzymes, in particular for use in kits and for use in effecting DNA-analysis or RNA-analysis and for enzyme preparations; all aforementioned goods for industrial and scientific purposes; reagents for scientific purposes
Goods and ServicesScientific and technological services, namely, scientific research, development, diagnosis and analysis in the field of diagnostic chemicals and reagents, sorting of nucleotides, separation processes and cleaning processes, chemical screening analysis and effecting of diagnostic, forensic and genetic-medical tests for thirds; scientific research and development for thirds in the fields of diagnostic chemical agents and reagents for use as diagnostic, therapeutic preparations, as well as chemical screenings and diagnosis for thirds; scientific research and development of pharmaceutical preparations for sanitary use; design of new products regarding pharmaceutical products; quality tests and quality control of scientific analyses relating to nucleic acids; scientific analyses relating to nucleic acids, in particular for detection purposes

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, July 7, 2018
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateSaturday, July 7, 2018
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeG - NOT AVAILABLE
Class Status DateWednesday, May 21, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameIMBA - Institut für Molekulare Biotechnologie GmbH
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressWien A-1030
AT

Party NameIMBA - Institut für Molekulare Biotechnologie GmbH
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressWien A-1030
AT

Party NameIMBA - Institut für Molekulare Biotechnologie GmbH
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressWien A-1030
AT

Trademark Events


Event DateEvent Description
Thursday, July 5, 2018SN ASSIGNED FOR SECT 66A APPL FROM IB
Saturday, July 7, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, July 7, 2018ASSIGNED TO EXAMINER
Saturday, July 7, 2018NON-FINAL ACTION WRITTEN
Sunday, July 8, 2018NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, July 11, 2018APPLICATION FILING RECEIPT MAILED
Wednesday, July 18, 2018REFUSAL PROCESSED BY MPU
Wednesday, July 18, 2018NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, August 4, 2018REFUSAL PROCESSED BY IB
Monday, August 27, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, September 11, 2018ASSIGNED TO LIE
Tuesday, September 11, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 11, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 17, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, October 17, 2018NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, October 17, 2018NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Friday, November 2, 2018NOTIFICATION PROCESSED BY IB
Thursday, September 27, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 22, 2019REGISTERED-PRINCIPAL REGISTER
Monday, April 22, 2019FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Wednesday, May 8, 2019GENERIC MADRID TRANSACTION CREATED
Saturday, June 1, 2019FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, January 22, 2024COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Wednesday, January 22, 2025TEAS SECTION 71 RECEIVED
Tuesday, November 6, 2018PUBLISHED FOR OPPOSITION
Tuesday, November 6, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, May 8, 2019GENERIC MADRID TRANSACTION SENT TO IB
Friday, November 26, 2021NEW REPRESENTATIVE AT IB RECEIVED
Saturday, November 4, 2023NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, February 11, 2025TEAS SECTION 15 RECEIVED
Monday, May 19, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, May 21, 2025REGISTERED - PARTIAL SEC 71 ACCEPTED
Wednesday, May 21, 2025REGISTERED - SEC. 15 ACKNOWLEDGED
Wednesday, May 21, 2025NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Wednesday, May 21, 2025SEC. 15 ACKNOWLEDGEMENT - E-MAILED